Tumor Grade Clinical Trials

7 recruitingLast updated: May 13, 2026

There are 7 actively recruiting tumor grade clinical trials across 5 countries. Studies span Phase 2, Not Applicable, Phase 3. Top locations include Amsterdam, Netherlands, Buffalo, New York, United States, Iowa City, Iowa, United States. Updated daily from ClinicalTrials.gov.


Tumor Grade Trials at a Glance

7 actively recruiting trials for tumor grade are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Amsterdam, Buffalo, and Iowa City. Lead sponsors running tumor grade studies include Abramson Cancer Center at Penn Medicine, Institut Paoli-Calmettes, and AC Camargo Cancer Center.

Browse tumor grade trials by phase

Treatments under study

About Tumor Grade Clinical Trials

Looking for clinical trials for Tumor Grade? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tumor Grade trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tumor Grade clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

ClinicalDevelopment of the Virtual BiopsyTumor Grade+2 more
Poitiers University Hospital500 enrolled1 locationNCT04313140
Recruiting
Phase 2

CapTemY90 for Grade 2/3 NET Liver Metastases

Neuroendocrine TumorsNeuroendocrine Tumor Grade 2
Abramson Cancer Center at Penn Medicine70 enrolled4 locationsNCT04339036
Recruiting
Phase 2

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2
University of Iowa120 enrolled1 locationNCT06395402
Recruiting
Not Applicable

Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors

Neuroendocrine Tumor Grade 1Neuroendocrine Tumor of Pancreas (Disorder)
Institut Paoli-Calmettes82 enrolled1 locationNCT04520932
Recruiting

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

Neuroendocrine NeoplasmNeuroendocrine TumorsNeuroendocrine Carcinoma+2 more
University of Roma La Sapienza60 enrolled1 locationNCT04464122
Recruiting
Phase 2Phase 3

Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial

Neuroendocrine NeoplasmNeuroendocrine TumorsNeuroendocrine Tumor Grade 1+1 more
The Netherlands Cancer Institute39 enrolled1 locationNCT06855095
Recruiting
Phase 2

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Neuroendocrine TumorsProgressionNeuroendocrine Tumor of Pancreas+4 more
AC Camargo Cancer Center100 enrolled2 locationsNCT06472388